偶然发现低级别胶质瘤的手术治疗
该研究基于1997至2019年加州大学旧金山分校前瞻性登记数据,比较偶然发现低级别胶质瘤(iLGG)与症状性低级别胶质瘤(sLGG)的手术结局。
要点
- iLGG占低级别胶质瘤首次切除的17.2%,肿瘤体积显著小于sLGG
- iLGG完全切除率57%,显著高于sLGG的23.8%
- iLGG总生存期显著长于sLGG,6个月神经功能缺损率4.4%
核心结论
- 偶然发现低级别胶质瘤患者肿瘤更小、切除程度更高、总生存期更长,手术并发症可接受,支持 upfront 最大安全切除。
主要发现
- iLGG中位术前观察时间3.1个月(范围1个月至12年),中位年增长速率3.9 cm3/年。
- iLGG肿瘤体积显著小于sLGG(22.5 vs 57.5 cm3,p<0.0001),完全切除FLAIR异常率57% vs 23.8%(p<0.001),残留体积2.9 vs 13.5 cm3(p<0.0001)。
- iLGG总生存期显著更长(中位未达到 vs 14.6年,p<0.0001),6个月神经功能缺损率4.4%。
关键数值与推荐
- iLGG定义为因与肿瘤无关的原因行神经影像学检查而发现的低级别胶质瘤。
- iLGG与sLGG在侧别、位置、分子病理诊断上无差异。
临床怎么用
- 对于偶然发现的低级别胶质瘤,可考虑 upfront 手术干预,目标为最大安全切除。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although most patients with low-grade glioma (LGG) present after a seizure, a small proportion is diagnosed after neuroimaging is performed for a sign or symptom unrelated to the tumor. While these tumors invariably grow, some surgeons argue for a watchful waiting approach. Here, the authors report on their experience in the surgical treatment of patients with incidental LGG (iLGG) and describe the neurological outcomes, survival, and complications. METHODS: Relevant cases were identified from a prospective registry of patients undergoing glioma resection at the University of California, San Francisco, between 1997 and 2019. Cases were considered iLGG when the lesion was noted on imaging performed for a reason unrelated to the tumor. Demographic, clinical, pathological, and imaging data were extracted from the electronic medical record. Tumor volumes, growth, and extent of resection were calculated from pre- and postoperative volumetric FLAIR sequences. RESULTS: One hundred thirteen of 657 (17.2%) first-time resections for LGG were for incidental lesions. The most common reasons for the discovery of an iLGG were headaches (without mass effect, 34.5%) or trauma (16.8%). Incidental tumors were no different from symptomatic lesions in terms of laterality or location, but they were significantly smaller (22.5 vs 57.5 cm3, p < 0.0001). There was no difference in diagnosis between patients with iLGG and those with symptomatic LGG (sLGG), incorporating both molecular and pathological data. The median preoperative observation time for iLGG was 3.1 months (range 1 month-12 years), and there was a median growth rate of 3.9 cm3/year. Complete resection of the FLAIR abnormality was achieved in 57% of patients with incidental lesions but only 23.8% of symptomatic lesions (p < 0.001), and the residual volumes were smaller for iLGGs (2.9 vs 13.5 cm3, p < 0.0001). Overall survival was significantly longer for patients with incidental tumors (median survival not reached for patients with iLGG vs 14.6 years for those with sLGG, p < 0.0001). There was a 4.4% rate of neurological deficits at 6 months. CONCLUSIONS: The authors present the largest cohort of iLGGs. Patient age, tumor location, and molecular genetics were not different between iLGGs and sLGGs. Incidental tumors were smaller, a greater extent of resection could be achieved, and overall survival was improved compared to those for patients with sLGG. Operative morbidity and rates of neurological deficit were acceptably low; thus, the authors advocate upfront surgical intervention aimed at maximal safe resection for these incidentally discovered lesions.
引用
- Gogos AJ, Young JS, Pereira MP, et al. Surgical management of incidentally discovered low-grade gliomas. J Neurosurg. 2020. PMID: 33007758. doi:10.3171/2020.6.JNS201296
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。